Latin America Vaccine Adjuvants Market Size & Outlook
Related Markets
Latin America vaccine adjuvants market highlights
- The Latin America vaccine adjuvants market generated a revenue of USD 274.8 million in 2025.
- The market is expected to grow at a CAGR of 5.9% from 2026 to 2033.
- In terms of segment, particulate was the largest revenue generating type in 2025.
- Pathogen is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
| Market revenue in 2025 | USD 274.8 million |
| Market revenue in 2033 | USD 426.6 million |
| Growth rate | 5.9% (CAGR from 2026 to 2033) |
| Largest segment | Particulate |
| Fastest growing segment | Pathogen |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pathogen, Adjuvant Emulsion, Particulate, Combination adjuvants |
| Key market players worldwide | GlaxoSmithKline, Novavax Inc, Adjuvance Technologies, Associated British Foods PLC, CSL Ltd, InvivoGen, Agenus Inc, Brenntag Biosector |
Other key industry trends
- In terms of revenue, Latin America region accounted for 7.0% of the global vaccine adjuvants market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,472.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Vaccine Adjuvants Market Scope
Vaccine Adjuvants Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Brenntag Biosector | View profile | - | Ballerup, Hovedstaden, Denmark, Europe | - |
| Agenus Inc | View profile | 389 | 3 Forbes Road, Lexington, MA, United States, 02421 | https://www.agenusbio.com |
| Adjuvance Technologies | View profile | 11-50 | Lincoln, Nebraska, United States, North America | http://adjuvancetechnologies.com/ |
| Novavax Inc | View profile | 1992 | 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878 | https://www.novavax.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| InvivoGen | View profile | 101-250 | Toulouse, Midi-Pyrenees, France, Europe | http://invivogen.com |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Associated British Foods PLC | View profile | 133000 | 10 Grosvenor Street, Weston Centre, London, United Kingdom, W1K 4QY | https://www.abf.co.uk |
Latin America vaccine adjuvants market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine adjuvants market will help companies and investors design strategic landscapes.
Particulate was the largest segment with a revenue share of 30.68% in 2025. Horizon Databook has segmented the Latin America vaccine adjuvants market based on pathogen, adjuvant emulsion, particulate, combination adjuvants covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Latin America vaccine adjuvants market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America vaccine adjuvants market databook
-
Our clientele includes a mix of vaccine adjuvants market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America vaccine adjuvants market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America vaccine adjuvants market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America vaccine adjuvants market size, by country, 2021-2033 (US$M)
Latin America Vaccine Adjuvants Market Share, 2025 & 2033 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
